Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Rating) shares traded down 7.9% during trading on Wednesday . The stock traded as low as $28.37 and last traded at $28.44. 871,116 shares traded hands during mid-day trading, an increase of 8% from the average session volume of 806,770 shares. The stock had previously closed at $30.89. Analyst […]
Connective Portfolio Management LLC bought a new stake in Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 15,000 shares of the company’s stock, valued at approximately $492,000. A number of other hedge funds and other […]
Moody Aldrich Partners LLC acquired a new stake in Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Rating) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 79,250 shares of the company’s stock, valued at approximately $2,599,000. Moody Aldrich Partners LLC owned approximately […]
Should You Buy or Sell Ventyx Biosciences Stock? Get The Latest VTYX Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Ventyx Biosciences (NASDAQ:VTYX – Get Rating) had its price target lowered by Oppenheimer from $65.00 to $62.00 in a report issued on Friday, Benzinga reports. The firm currently has an outperform rating on the stock. Oppenheimer also issued estimates for Ventyx Biosciences’ FY2026 earnings at ($2.75) EPS and FY2027 earnings at ($2.89) EPS. A number […]